MAP.AX

Healthcare Diagnostics & Research

Microba Life Sciences Limited

A$0.05

-0.00 -2.04% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 1:45 PM ET	0.05

Key Stats

Market Cap

34.42M

Avg Volume

361,374

EPS

-A$0.03

52W High

A$0.11

52W Low

A$0.04

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-20.25

P/B Ratio

1.37

P/S Ratio

2.28

EV/EBITDA

-1.60

EV/Revenue

2.02

Margins

Gross Margin 47.6%

Operating Margin (126.4%)

Net Margin (140.4%)

EBITDA Margin (126.4%)

Growth & Returns

Revenue Growth (YoY)

(1.9%)

Return on Equity

(72.9%)

Return on Assets

(29.1%)

Liquidity & Leverage

Current Ratio

1.24

Quick Ratio

1.00

Debt / Equity

0.17

Total Cash

7.95M

Total Debt

4.11M

About

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through, Testing Services and Supplements, and Research and Development segments. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; microba microbiome explorer; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel autoimmune diseases, oncology, and allergy. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.

microba.com